Avantax Advisory Services’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Avantax Advisory Services’s Portfolio DMK Stock Details DMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-314	Closed	-$4K	–	1473
2022 Q3	$4K	Hold	314	–	–	﹤0.01%	1325
2022 Q2	$11K	Hold	314	–	–	﹤0.01%	1296
2022 Q1	$13K	Sell	314 -457	-59%	-$19.6K	﹤0.01%	1274
2021 Q4	$33K	Buy	771 +314	+69%	+$19.6K	﹤0.01%	1236
2021 Q3	$31K	Hold	457	–	–	﹤0.01%	1167
2021 Q2	$35K	Buy	+457	New	+$27.8K	﹤0.01%	1130
2020 Q3	–	Sell	-243	Closed	-$9K	–	1400
2020 Q2	$9K	Hold	243	–	–	﹤0.01%	851
2020 Q1	$6K	Hold	243	–	–	﹤0.01%	801
2019 Q4	$12K	Buy	243 +100	+70%	+$4.85K	﹤0.01%	827
2019 Q3	$7K	Buy	+143	New	+$10.3K	﹤0.01%	566

Other funds holding DMK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

EDRH

Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Avantax Advisory Services's DMK Position: Q4 2022 in Review

Avantax Advisory Services sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q4 2022, closing a stake of 314 shares — an estimated $4K sold.

Avantax Advisory Services first reported a position in DMK in Q3 2019 and held it in 10 quarters. The position peaked at $35K in Q2 2021. 48 funds tracked by Wall St. Rank hold DMK as of Q4 2022.

Avantax Advisory Services reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q4 2022 after selling out during the quarter.
Avantax Advisory Services sold 314 DMK Pharmaceuticals Corporation Common Stock shares in Q4 2022, an estimated $4K.
Avantax Advisory Services first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q3 2019 and held it in 10 quarters.
Avantax Advisory Services's DMK Pharmaceuticals Corporation Common Stock position peaked at $35K in Q2 2021.
48 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q4 2022.

Based on Avantax Advisory Services's 13F filing for Q4 2022, filed 13 Feb 2023.